9,000 Shares in Amedisys, Inc. (NASDAQ:AMED) Purchased by Moore Capital Management LP

Moore Capital Management LP bought a new stake in Amedisys, Inc. (NASDAQ:AMED) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 9,000 shares of the health services provider’s stock, valued at approximately $817,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Blue Trust Inc. lifted its holdings in Amedisys by 55.1% in the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider’s stock valued at $34,000 after purchasing an additional 124 shares in the last quarter. Xponance Inc. lifted its holdings in Amedisys by 3.5% in the 4th quarter. Xponance Inc. now owns 4,349 shares of the health services provider’s stock valued at $395,000 after purchasing an additional 148 shares in the last quarter. Inspire Investing LLC lifted its holdings in Amedisys by 3.6% in the 4th quarter. Inspire Investing LLC now owns 4,405 shares of the health services provider’s stock valued at $400,000 after purchasing an additional 155 shares in the last quarter. Gamco Investors INC. ET AL lifted its holdings in Amedisys by 0.5% in the 4th quarter. Gamco Investors INC. ET AL now owns 30,334 shares of the health services provider’s stock valued at $2,754,000 after purchasing an additional 159 shares in the last quarter. Finally, Nisa Investment Advisors LLC lifted its holdings in Amedisys by 1.2% in the 4th quarter. Nisa Investment Advisors LLC now owns 15,150 shares of the health services provider’s stock valued at $1,375,000 after purchasing an additional 180 shares in the last quarter. 94.36% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on AMED. Royal Bank of Canada reaffirmed an “outperform” rating and set a $100.00 price objective on shares of Amedisys in a research note on Wednesday, April 16th. Stephens reaffirmed an “equal weight” rating and set a $101.00 price objective on shares of Amedisys in a research note on Tuesday, March 4th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $100.75.

Amedisys Trading Down 1.0%

NASDAQ AMED opened at $94.50 on Wednesday. Amedisys, Inc. has a 12 month low of $82.15 and a 12 month high of $98.95. The company has a 50-day moving average of $93.09 and a 200-day moving average of $91.66. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. The company has a market cap of $3.10 billion, a P/E ratio of 37.50, a P/E/G ratio of 1.78 and a beta of 0.96.

Amedisys (NASDAQ:AMED) last posted its earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.13 by $0.12. The firm had revenue of $594.78 million during the quarter, compared to the consensus estimate of $597.43 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The company’s revenue was up 4.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.03 EPS. As a group, equities analysts predict that Amedisys, Inc. will post 4.4 earnings per share for the current year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.